Table 4

Potency of methylphenidate and analogs for producing cocaine-like discriminative effects

CompoundED50 (95% Confidence Limits)4-aRelative Potency4-b
mg/kgμmol/kg
3,4CTMP0.38 (0.2–0.73)0.43 (0.13–1.36)c 7.98
4FTMP0.26 (0.18–0.36)1.03 (0.72–1.43)c d 3.33
3CTMP0.38 (0.20–0.73)1.42 (0.75–2.73)c d e 2.42
4ATMP0.39 (0.09–1.79)1.57 (0.36–7.22)c d e 2.18
TMP0.80 (0.61–1.05)3.43 (2.62–4.51)d e f 1.00
4MeTMP1.15 (0.25–5.33)4.65 (1.01–21.6)e f 0.74
3CTMPNMe2.004-150 7.104-150 0.48
Cocaine2.58 (2.03–3.28)8.45 (6.66–10.8)0.41
TROMeNBn8.28 (2.46–27.9)26.7 (7.94–90.0)g 0.13
TROHNBn9.404-150 31.64-150 0.11
4MeTMPNMe9.06 (3.24–25.4)34.7 (12.4–97.3)g 0.10
TMPNMe11.4 (3.47–37.2)46.1 (14.0–151)g 0.07
TMPNBn>30>92<0.04
  • 4-a  Dose resulting in selection of the cocaine-appropriate choice lever in an average of 10 trials per session [n = 5 for all drugs except TROHNBn (n = 4) and cocaine (n = 23)].

  • 4-b  Potency relative to methylphenidate, based upon ED50 values (μmol/kg).

  • c–g ED50 values that do not have a superscript in common are significantly different from each other, p < 0.05.

  • 4-150  Estimated from group means and not included in the ANOVA of ED50 values.